BTCY — what changed in the latest 10-Q
A section-by-section comparison of BTCY's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-19 vs the prior 10-Q · 2026-02-11
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +126 | −166 | ~27 | 87 |
| Market risk (Item 3) | Text added/removed | +126 | −166 | ~26 | 87 |
| Controls & procedures | Text added/removed | +126 | −166 | ~26 | 87 |
| Legal proceedings | Text added/removed | +126 | −166 | ~26 | 87 |
| Risk factors | Some risk factors updated | +126 | −166 | ~26 | 87 |
| Other information | Text added/removed | +126 | −166 | ~25 | 87 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-19
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 6,023,510 6,446,488
Selling, general and administrative expenses 2,699,308 2,138,692
Gain/(Loss) upon convertible promissory notes conversion and redemption [Note 8] — 8,433
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 23,096,373 26,284,734
Exchange of Common shares warrants and Options to Preferred C Shares
Text removed vs the prior filing · source: 10-Q · 2026-02-11
Preferred stock, $0.001 par value, 9,979,400 shares authorized as of December 31, 2025 and March 31, 2025, respectively, 1 share Special Voting Preferred Stock issued and outstanding as of December 31, 2025 and March 31, 2025 [Note 9] 1 1
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 5,686,495 5,640,954
FOR THE NINE MONTHS ENDED DECEMBER 31, 2025 AND 2024 (UNAUDITED)
Proceeds from (repayment to) convertible debentures, net (77,003) 1,337,898
Proceeds from (repayment to) short term loan and promissory notes, net 1,544,318 (1,407,544)
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-08-19
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 6,023,510 6,446,488
Selling, general and administrative expenses 2,699,308 2,138,692
Gain/(Loss) upon convertible promissory notes conversion and redemption [Note 8] — 8,433
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 23,096,373 26,284,734
Exchange of Common shares warrants and Options to Preferred C Shares
Text removed vs the prior filing · source: 10-Q · 2026-02-11
Preferred stock, $0.001 par value, 9,979,400 shares authorized as of December 31, 2025 and March 31, 2025, respectively, 1 share Special Voting Preferred Stock issued and outstanding as of December 31, 2025 and March 31, 2025 [Note 9] 1 1
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 5,686,495 5,640,954
FOR THE NINE MONTHS ENDED DECEMBER 31, 2025 AND 2024 (UNAUDITED)
Proceeds from (repayment to) convertible debentures, net (77,003) 1,337,898
Proceeds from (repayment to) short term loan and promissory notes, net 1,544,318 (1,407,544)
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-08-19
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 6,023,510 6,446,488
Selling, general and administrative expenses 2,699,308 2,138,692
Gain/(Loss) upon convertible promissory notes conversion and redemption [Note 8] — 8,433
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 23,096,373 26,284,734
Exchange of Common shares warrants and Options to Preferred C Shares
Text removed vs the prior filing · source: 10-Q · 2026-02-11
Preferred stock, $0.001 par value, 9,979,400 shares authorized as of December 31, 2025 and March 31, 2025, respectively, 1 share Special Voting Preferred Stock issued and outstanding as of December 31, 2025 and March 31, 2025 [Note 9] 1 1
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 5,686,495 5,640,954
FOR THE NINE MONTHS ENDED DECEMBER 31, 2025 AND 2024 (UNAUDITED)
Proceeds from (repayment to) convertible debentures, net (77,003) 1,337,898
Proceeds from (repayment to) short term loan and promissory notes, net 1,544,318 (1,407,544)
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-08-19
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 6,023,510 6,446,488
Selling, general and administrative expenses 2,699,308 2,138,692
Gain/(Loss) upon convertible promissory notes conversion and redemption [Note 8] — 8,433
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 23,096,373 26,284,734
Exchange of Common shares warrants and Options to Preferred C Shares
Text removed vs the prior filing · source: 10-Q · 2026-02-11
Preferred stock, $0.001 par value, 9,979,400 shares authorized as of December 31, 2025 and March 31, 2025, respectively, 1 share Special Voting Preferred Stock issued and outstanding as of December 31, 2025 and March 31, 2025 [Note 9] 1 1
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 5,686,495 5,640,954
FOR THE NINE MONTHS ENDED DECEMBER 31, 2025 AND 2024 (UNAUDITED)
Proceeds from (repayment to) convertible debentures, net (77,003) 1,337,898
Proceeds from (repayment to) short term loan and promissory notes, net 1,544,318 (1,407,544)
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-08-19
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 6,023,510 6,446,488
Selling, general and administrative expenses 2,699,308 2,138,692
Gain/(Loss) upon convertible promissory notes conversion and redemption [Note 8] — 8,433
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 23,096,373 26,284,734
Exchange of Common shares warrants and Options to Preferred C Shares
Text removed vs the prior filing · source: 10-Q · 2026-02-11
Preferred stock, $0.001 par value, 9,979,400 shares authorized as of December 31, 2025 and March 31, 2025, respectively, 1 share Special Voting Preferred Stock issued and outstanding as of December 31, 2025 and March 31, 2025 [Note 9] 1 1
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 5,686,495 5,640,954
FOR THE NINE MONTHS ENDED DECEMBER 31, 2025 AND 2024 (UNAUDITED)
Proceeds from (repayment to) convertible debentures, net (77,003) 1,337,898
Proceeds from (repayment to) short term loan and promissory notes, net 1,544,318 (1,407,544)
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-19
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 6,023,510 6,446,488
Selling, general and administrative expenses 2,699,308 2,138,692
Gain/(Loss) upon convertible promissory notes conversion and redemption [Note 8] — 8,433
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 23,096,373 26,284,734
Exchange of Common shares warrants and Options to Preferred C Shares
Text removed vs the prior filing · source: 10-Q · 2026-02-11
Preferred stock, $0.001 par value, 9,979,400 shares authorized as of December 31, 2025 and March 31, 2025, respectively, 1 share Special Voting Preferred Stock issued and outstanding as of December 31, 2025 and March 31, 2025 [Note 9] 1 1
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 5,686,495 5,640,954
FOR THE NINE MONTHS ENDED DECEMBER 31, 2025 AND 2024 (UNAUDITED)
Proceeds from (repayment to) convertible debentures, net (77,003) 1,337,898
Proceeds from (repayment to) short term loan and promissory notes, net 1,544,318 (1,407,544)
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice